| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Filociclovir | 2.20-4.90 | Range of values between Low level resistance and Intermediate level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020) | |
| Maribavir | 1.90 | No resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. (Feb 2024) | |
| Ganciclovir | 6.90 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. (Feb 2024) |
| Mutant | Resistances |
|---|---|
| A594E |
Ganciclovir:
|
| A594G |
Ganciclovir:
|
| A594P |
Ganciclovir:
|
| A594P |
Maribavir:
|
| A594S |
Ganciclovir:
|
| A594T |
Ganciclovir:
|
| A594T |
Maribavir:
|